Pudendal Nerve Block With Bupivacaine Alone and Bupivacaine With Methylene Blue for Postoperative Analgesia

Launched by NEPAL MEDICITI HOSPITAL · Aug 6, 2023

Keywords

ClinConnect Summary

This clinical trial is studying two different methods of providing pain relief after perianal surgery, which includes procedures for conditions like hemorrhoids and anal fissures. The researchers want to find out if adding a dye called Methylene Blue to a common anesthetic called Bupivacaine can make pain relief last longer after surgery compared to using Bupivacaine alone. Participants will be randomly assigned to one of two groups: one group will receive the combination of Bupivacaine and Methylene Blue, while the other group will receive only Bupivacaine.

To be eligible for this study, participants should be adults in good health (ASA physical status I or II) who are scheduled for elective perianal surgery with spinal anesthesia. Those with specific conditions, like allergies to the medications, bleeding disorders, or certain spinal issues, will not be able to participate. During the trial, participants will have their pain levels monitored after surgery, and researchers will track how long the pain relief lasts and how satisfied patients are with their pain management. This study aims to improve pain control strategies for people undergoing these types of surgeries, potentially reducing the need for stronger pain medications.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All patients of ASA I and II undergoing elective perianal surgery under spinal anesthesia
• Exclusion Criteria:
• • 1. Patient's refusal
• • 2. Patient with a history of allergy to the local anesthetic or Methylene blue
• • 3. Bleeding diathesis or coagulopathy
• • 4. Extensive infection at the site of injection
• • 5. Pregnancy and lactating mother
• • 6. Spinal abnormality
• • 7. Patients with neurological deficit